Cargando…

Presence of cutaneous lesion is a poor prognostic factor in patients with smoldering-type adult T-cell leukemia-lymphoma

Detalles Bibliográficos
Autores principales:	Yonekura, Kentaro, Utsunomiya, Atae, Kawai, Kazuhiro, Takatsuka, Yoshifusa, Takeuchi, Shogo, Tokunaga, Masahito, Kubota, Ayumu, Kanzaki, Tamotsu, Uchida, Youhei, Kanekura, Takuro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112747/ http://dx.doi.org/10.1186/1742-4690-8-S1-A35

Ejemplares similares

Effect of a novel anti-CCR4 monoclonal antibody (Mogamulizmab) on skin lesions of adult T-cell leukemia-lymphoma (ATL) and its adverse skin reactions (ASR)
por: Yonekura, Kentaro, et al.
Publicado: (2014)

Cutaneous adverse reactions and anti-tumor effects of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma
por: Yonekura, Kentro, et al.
Publicado: (2015)

Chronic type adult T-cell leukemia-lymphoma after autolougous stem cell transplantation for ALK-negative anaplastic large cell lymphoma
por: Utsunomiya, Atae, et al.
Publicado: (2015)

A phase II study of bortezomib in patients with relapsed or refractory aggressive adult T-cell leukemia/lymphoma
por: Ishitsuka, Kenji, et al.
Publicado: (2015)

Nevus Lipomatosus Cutaneous Superficialis Associated with Trichofolliculoma on the Lower Leg
por: Sakanoue, Masanao, et al.
Publicado: (2013)

Microcystic Adnexal Carcinoma with Xanthomatous Reaction
por: FUJII, Kazuyasu, et al.
Publicado: (2021)

Smoldering cutaneous course of lymphomatoid granulomatosis
por: Russell, Devin P., et al.
Publicado: (2022)

Microcystic Adnexal Carcinoma Arising in a Nevus Sebaceous
por: Sakanoue, Masanao, et al.
Publicado: (2013)

A Case of Kimura's Disease as Giant Pedunculated Tumors
por: Sakanoue, Masanao, et al.
Publicado: (2014)

Scleromyxedema Clinically Resembling to Scleroderma
por: Aoki, Megumi, et al.
Publicado: (2016)

Presence of clonal T cell populations in chronic B lymphocytic leukemia and smoldering myeloma
Publicado: (1990)

Serum prohepcidin levels are potential prognostic markers in patients with multiple myeloma
por: HARAGUCHI, KOUICHI, et al.
Publicado: (2012)

Smoldering Multiple Myeloma
por: Gao, Minjie, et al.
Publicado: (2015)

CD147 Is Essential for the Development of Psoriasis via the Induction of Th17 Cell Differentiation
por: Okubo, Aoi, et al.
Publicado: (2021)

Smoldering mantle cell lymphoma
por: Ye, Haige, et al.
Publicado: (2017)

Metabolic Control of Smoldering Neuroinflammation
por: Peruzzotti-Jametti, Luca, et al.
Publicado: (2021)

Next-Generation Sequencing Technologies for Early-Stage Cutaneous T-Cell Lymphoma
por: Fujii, Kazuyasu, et al.
Publicado: (2019)

Smoldering ashes : Cuzco and the creation of Republican Peru, 1780-1840 /
por: Walker, Charles, 1959-
Publicado: (1999)

Clinical significance of TP53 mutations in adult T‐cell leukemia/lymphoma
por: Sakamoto, Yuma, et al.
Publicado: (2021)

CCR7 alterations associated with inferior outcome of adult T‐cell leukemia/lymphoma under mogamulizumab treatment
por: Sakamoto, Yuma, et al.
Publicado: (2022)

Immunotherapeutic potential of varicella vaccine in smoldering and cutaneous adult T-cell leukemia/lymphoma
por: Amano, M, et al.
Publicado: (2014)

Letter re: SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis
por: Baba, Atsunori, et al.
Publicado: (2023)

Genomic patterns of progression in smoldering multiple myeloma
por: Bolli, Niccolò, et al.
Publicado: (2018)

Gazing into smoldering volcanoes: precision cardiac imaging
por: Moss, Alastair J, et al.
Publicado: (2018)

Smoldering myocarditis following immune checkpoint blockade
por: Norwood, Timothy G., et al.
Publicado: (2017)

Smoldering Multiple Myeloma Arising in Ulcerative Colitis
por: Yang, Xue, et al.
Publicado: (2018)

Hashimoto's Encephalopathy Presenting with Smoldering Limbic Encephalitis
por: Nagano, Masahiro, et al.
Publicado: (2019)

How we manage smoldering multiple myeloma
por: Romano, Alessandra, et al.
Publicado: (2020)

Recent Advances in the Management of Smoldering Multiple Myeloma
por: Madhira, Bhaskara Reddy, et al.
Publicado: (2020)

How We Approach Smoldering Multiple Myeloma
por: Raje, Noopur, et al.
Publicado: (2020)

Systemic Mastocytosis Associated with “Smoldering” Multiple Myeloma
por: Zanelli, Magda, et al.
Publicado: (2021)

What Is New in the Treatment of Smoldering Multiple Myeloma?
por: Bolli, Niccolo’, et al.
Publicado: (2021)

Risk Stratification and Treatment in Smoldering Multiple Myeloma
por: Lussier, Tyler, et al.
Publicado: (2021)

How I approach smoldering multiple myeloma
por: Vaxman, Iuliana, et al.
Publicado: (2022)

Smoldering multiple myeloma current treatment algorithms
por: Rajkumar, S. Vincent, et al.
Publicado: (2022)

Did dupilumab unmask smoldering mycosis fungoides?
por: Toker, Michelle, et al.
Publicado: (2023)

Expression of the TCL1 Gene at 14q32 in B‐Cell Malignancies but Not in Adult T‐Cell Leukemia
por: Takizawa, Jun, et al.
Publicado: (1998)

Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
por: Utsunomiya, Atae
Publicado: (2014)

Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma
por: Utsunomiya, Atae
Publicado: (2019)

Treatment of Smoldering Multiple Myeloma: Ready for Prime Time?
por: Kim, E. Bridget, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ucpmhlbg6135qq05t0tjvrog9p